v3.25.2
Fair Value Measurements - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 29, 2025
Jun. 29, 2024
Mar. 30, 2024
Dec. 30, 2023
Jun. 28, 2025
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Impairment of intangible assets, finite-lived $ 204,000,000        
2028 Senior Notes          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Fair value of debt instrument         $ 396,800,000
2029 Senior Notes          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Fair value of debt instrument         905,100,000
Credit Agreement          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Borrowed principal         $ 1,170,000,000
2028 Senior Notes | Senior Notes          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Stated interest rate         4.625%
2029 Senior Notes | Senior Notes          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Stated interest rate         3.25%
Acessa          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Impairment of intangible assets, finite-lived 61,900,000        
Finite-lived intangibles 7,200,000        
Bolder          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Impairment of intangible assets, finite-lived 64,500,000        
Finite-lived intangibles 0        
Diagenode          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Impairment of intangible assets, finite-lived 38,600,000        
Finite-lived intangibles 3,000,000        
Mobidiag          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Impairment of intangible assets, finite-lived 39,000,000        
Finite-lived intangibles 6,700,000        
Mobidiag | In-process research and development          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Intangible asset impairment charges 16,900,000     $ 4,300,000  
Intangible assets, current $ 5,000,000     22,400,000  
Mobidiag | Right of use asset          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Intangible asset impairment charges       12,500,000  
Mobidiag | Right of use asset | In-process research and development          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Intangible assets, current       $ 0  
Developed technology | BioZorb          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Impairment of intangible assets, finite-lived   $ 13,300,000 $ 25,900,000    
Finite-lived intangibles     13,900,000    
Intangible assets, current   0      
Trade Names | BioZorb          
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]          
Impairment of intangible assets, finite-lived   $ 400,000 900,000    
Finite-lived intangibles     $ 500,000